Page results
-
We do not accept self-referrals into the adult hearing aid service. All new patients must be either referred by their GP or referred from another UCLH service. When contacting the department to…
-
Are you interested in knowing more about how you can work at UCLH? The drop-down menu options below, provide information and contact details for our various options. Please note,…
-
The diagram below shows a typical appointment pathway through our service. Some patients require additional appointments to this, and some require less. The number of appointments needed will depend…
-
If you are a health professional and would like to discuss a patient, the best way to refer to us is as follows. Emergencies and urgent assessments (0-17 years) Please telephone the on-call…
-
Insulin pumps don’t often stop working, but this can happen for technical reasons or due to damage to the pump. If your pump does fail, telephone the helpline for your pump company immediately.…
-
This page has been written for patients who are having a course of superficial radiotherapy for a skin tumour (such as a basal cell carcinoma or squamous cell carcinoma), or some other skin condition.
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
-
University College London Hospitals (UCLH) is now administering new COVID-19 treatments for patients at highest risk in the community.
File results
-
FOI/2022/0551 - Procurement contact details
-
FOI/2022/0555 - Senior staff contact details
-
FOI/2022/0563 - Ambulatory cardiac monitoring
-
FOI/2022/0542 - Infection control audits from September 2020 to April 2021
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0559 - Proton Beam Therapy contract
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology